Top Markets
#1 Tensor Tensor +34.42%
#2 Blur Blur +19.40%
#3 Ontology Gas Ontology Gas +17.50%
#4 XPIN Network XPIN Network +15.53%
#5 Dymension Dymension +14.91%
#6 Irys Irys +13.80%
#7 Corn Corn +11.17%
#8 Naoris Protocol Naoris Protocol +10.00%
#9 Tradoor Tradoor +9.51%
#10 Enjin Coin Enjin Coin +9.26%
Coin of the day
Tensor Tensor
Settings
Language
ENGLISH
Currency
USD
Theme
Clinical Laserthermia Systems AB (publ) Clinical Laserthermia Systems AB (publ)

Clinical Laserthermia Systems AB (publ)

CLS-B
Rank in Stocks #16822
Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased... Clinical Laserthermia Systems AB (publ) develops treatment tools for diseased tissue under the TRANBERG brand in Sweden. The company offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. It also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers provides multiple options to control treatment. In addition, the company offers various gauge laser applicators, as well as provides temperature and treatment monitoring devices. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Share Price
$0.51099792
Market Cap
$13.22M
Change (1 day)
-0.54%
Change (1 year)
99.27%
Country
SE
Trade Clinical Laserthermia Systems AB (publ) (CLS-B)

Category

Healthcare
P/B ratio for Clinical Laserthermia Systems AB (publ) (CLS-B)
P/B ratio as of April 2026 TTM: 1.99
According to Clinical Laserthermia Systems AB (publ) latest financial reports and stock price the company's current price-to-book ratio (TTM) is 1.99. At the end of 2023 the company had a P/B ratio of 2.03.
P/B ratio history for Clinical Laserthermia Systems AB (publ) from 2008 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 1.99 237.56%
2024 0.59 -71.05%
2023 2.03 -73.67%
2022 7.69 -28.81%
2021 10.81 -26.23%
2020 14.65 -50.47%
2019 29.58 587.26%
2018 4.30 -67.02%
2017 13.05 -1.35%
2016 13.23 45.08%
2015 9.12 115.27%
2014 4.24 -59.57%
2013 10.48 -99.58%
2012 2.49K -55.39%
2011 5.57K -3.48%
2010 5.77K 38.40%
2009 4.17K 8,518.09%
2008 48.40 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.438 72.63%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.606 181.48%
US
Medtronic plc Medtronic plc
Medtronic plc
2M6.DE
 2.2679 13.87%
IE
Medtronic Medtronic
Medtronic
MDT.US
 2.2679 13.87%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.8394 92.78%
US